Biomerica appoints former LabCorp Diagnostics CEO Gary Huff to board; director Emerson not standing for re-election

BIOMERICA INC

Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.
Huff receives annualized cash fee of $45,000 (paid quarterly); no equity compensation granted for board appointment.
Dr. Jane Emerson to step down after 18 years on board, not seeking re-election at Dec 12, 2025 annual meeting; board size to reduce to 5.
Huff brings 35+ years of lab industry experience, having served as CEO of LabCorp Diagnostics and Baylor Genetics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.